The unanimous accumulation by multiple high-conviction active managers suggests a shared catalyst thesis — likely upcoming clinical data or pipeline milestones. With zero sellers and $198.4M in net new capital deployed, traders should watch for near-term news flow that could validate this positioning. The 45-day 13F reporting lag means positions may have been adjusted since quarter-end, but the scale and unanimity of the cluster make it a strong bullish signal.
Executive Summary
A powerful institutional cluster emerged in Oruka Therapeutics (ORKA) during 2026-Q2, with 19 active asset managers accumulating $212.8M in new or increased positions and zero sellers. Major new stakes from Pictet ($58.9M), Massachusetts Financial Services ($34.7M), and Seb Asset Management ($18.7M), plus a massive doubling by Aberdeen Group to $61.6M, signal strong conviction in the company's pipeline.
Key Financial Metrics
Institutional Positions
Net institutional flow: $198.4M
▲ Buyers (19)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| Pictet Asset Management Holding | NEW | +0% | $58.9M | $58.9M |
| Massachusetts Financial Services | NEW | +0% | $34.7M | $34.7M |
| Aberdeen Group | DOUBLED | +754.8% | $61.6M | $57.9M |
| Jennison Associates | ADD | +69.4% | $28.5M | $19.8M |
| Seb Asset Management Ab | NEW | +0% | $18.7M | $18.7M |
Key Facts
- 19 institutional buyers, 0 sellers — unanimous accumulation direction
- Pictet Asset Management initiated a $58.9M position (NEW)
- Massachusetts Financial Services initiated a $34.7M position (NEW)
- Aberdeen Group nearly 8x'd its stake to $61.6M (DOUBLED)
- Jennison Associates added $19.8M to reach $28.5M (ADD +69.4%)
- Seb Asset Management initiated a $18.7M position (NEW)
- Aggregate current holdings of $212.8M represent ~3.5% of ORKA's $6.0B market cap
- All buyers are active asset managers — no passive/index fund signal dilution
Financial Impact
19 institutions accumulated $212.8M in ORKA during Q2 2026, with net new money of $198.4M. No institutional selling was recorded.
Risk Factors
- 13F data is 45+ days old; positions may have been partially or fully unwound since quarter-end
- No insider buying corroborates the institutional thesis (confluence score 24/100, divergent)
- Market cap of $6.0B implies high expectations; any pipeline setback could trigger sharp reversals
- Historical calibration shows only ~45% of score-7 bullish calls on this filing type moved up at T+20
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-ORKA-2026-Q2 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 15, 2026 16d ago | Insider Cluster | $93.55 $89.93 | ▼ −3.87% | ▼ −6.44% | — |
Sep 1, 2026 4w ago | Insider Cluster | $91.63 $91.65 | ▼ −0.02% | ▼ −0.98% | — |
Aug 28, 2026 5w ago | EFFECT | $91.15 $92.51 | ▼ −1.50% | ▼ −1.39% | — |
Aug 17, 2026 6w ago | Insider Cluster | $113.08 $101.82 | ▼ −9.96% | ▼ −9.76% | — |
Aug 10, 2026 7w ago | Press Release | $105.14 $112.66 | ▲ +7.15% | ▲ +7.20% | — |
Aug 10, 2026 7w ago | 8-K | $105.14 $112.66 | ▲ +7.15% | ▲ +7.20% | — |
Aug 9, 2026 7w ago | Institutional Cluster | $105.14 $112.66 | ▲ +7.15% | ▲ +7.20% | — |
Jul 15, 2026 11w ago | Insider Cluster | $83.04 $91.95 | ▲ +10.73% | ▲ +12.40% | — |
Jul 2, 2026 13w ago | Insider Cluster | $85.21 $88.27 | ▲ +3.59% | ▲ +2.66% | — |
Jun 22, 2026 14w ago | Insider Cluster | $83.40 $92.49 | ▲ +10.90% | ▲ +9.89% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access